CAS: 139262-76-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
H2L5186303 REF: AN-AG00A0N1CAS: 139262-76-3 | 98% | To inquire | Mon 10 Jun 24 | |
H2L5186303 REF: TM-T22835CAS: 139262-76-3 | 97.23% | 52.00 €~1,606.00 € | Tue 11 Jun 24 | |
H2L5186303 REF: 3D-PFA26276CAS: 139262-76-3 | Min. 95% | To inquire | Mon 22 Jul 24 |
Ref: AN-AG00A0N1
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 10 Jun 2024
H2L5186303
CAS:139262-76-3
H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.
Formula:
C26H20N2O8
Purity:
97.23%
Color and Shape:
Solid
Molecular weight:
488.45
Ref: TM-T22835
1mg | 52.00 € | ||
5mg | 95.00 € | ||
10mg | 172.00 € | ||
25mg | 369.00 € | ||
50mg | 547.00 € | ||
100mg | 786.00 € | ||
500mg | 1,606.00 € | ||
1ml*10 (DMSO) | 113.00 € |
Estimated delivery in United States, on Tuesday 11 Jun 2024
H2L5186303
CAS:139262-76-3
H2L5186303 is a synthetic endocannabinoid that has been shown to have anticancer effects. H2L5186303 binds …
Formula:
C26H20N2O8
Purity:
Min. 95%
Molecular weight:
488.45 g/mol
Ref: 3D-PFA26276
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 22 Jul 2024